Clinical Trial Update: Bortezomib With Steroid Pulse Therapy for Acute Cellular Rejection in Kidney Transplantation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing bortezomib with steroid pulse therapy for acute cellular rejection in kidney transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cellular Rejection
• Kidney Transplantation

Drugs mentioned

• Bortezomib (bortezomib)
• METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: Asan Medical Center | Conditions: Kidney Transplantation | Phase 3 | Status: UNKNOWN